Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

NCT00859469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: Oxaliplatin
DRUG: Gemcitabine

Sponsor

Columbia University